Details for Patent: 5,817,338

✉ Email this page to a colleague

Summary for Patent: 5,817,338

Patent landscape, scope, and claims:

Title:	Multiple unit tableted dosage form of omeprazole
Abstract:	A new pharmaceutical multiple unit tableted dosage form containing omeprazole or one of its single enantiomers or an alkaline salt of omeprazole or one of its single enantiomers, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
Inventor(s):	Bergstrand; Pontus John Arvid (Goteborg, SE), Lovgren; Kurt Ingmar (Molndal, SE)
Assignee:	Astra Aktiebolag (Sodertalje, SE)
Application Number:	08/454,395
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form; Compound; Process;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 5,817,338

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,817,338

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	9402432	Jul 08, 1994
Sweden	9402433	Jul 08, 1994

PCT Information
PCT Filed	June 07, 1995	PCT Application Number:	PCT/SE95/00677
PCT Publication Date:	January 25, 1996	PCT Publication Number:	WO96/01623

International Family Members for US Patent 5,817,338

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	206044	⤷ Subscribe
Austria	414509	⤷ Subscribe
Australia	2993795	⤷ Subscribe
Australia	695966	⤷ Subscribe
Brazil	1100458	⤷ Subscribe
Brazil	9506018	⤷ Subscribe
Canada	2170647	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.